Group: Randox
Catalog excerpts
Familial Hypercholesterolaemia (FH) Arrays Rapid and reliable genetic assessment of patients with suspected FH
Open the catalog to page 1Familial Hypercholesterolaemia (FH) Arrays I & II Rapid, simultaneous detection of 40 mutations within the LDLR, ApoB and PCSK9 genes Introduction Familial Hypercholesterolemia (FH) is a genetic disorder of lipoprotein metabolism. It is a common autosomal dominant, or inherited, disease which affects the plasma clearance of LDL-cholesterol (LDL-C), resulting in premature onset of cardiovascular disease (CVD) and a higher mortality risk.1-3 Common genetic defects in FH are attributed to mutations in three genes encoding proteins involved in the uptake of LDL-C from the plasma: the low...
Open the catalog to page 2Analyte Name Analyte Name FH Arrays I & II protocol Extraction Genomic DNA extracted from blood Amplicon hybridisation/ conjugation to biochip array results processing by Evidence Investigator analyser Benefits of the Randox Familial Hypercholesterolaemia (FH) Arrays I & II Product features • Rapid turnaround time of ~3 hours from extracted genomic DNA to result • Samples can be assessed in small batches (as few as 3 samples) with only 20ng of genomic DNA required per array Benefits to the laboratory • Developed with leading experts to test for 40 specific FH-causing mutations with ~78%...
Open the catalog to page 3PRECISE DIAGNOSTICS FOR TARGETED THERAPY Understanding drivers of disease is vital in delivering effective patient care. Through the unravelling of the genetic code, healthcare practitioners are able to predict and prevent disease and prescribe appropriate targeted treatments to specific subgroups, for optimal patient outcomes. Randox Molecular offers a range of assay formats including SNP genotyping, gene expression, pathogen detection and mutation detection across infectious diseases, cardiovascular disease and oncology. Utilising innovative Biochip Array Technology (BAT) for...
Open the catalog to page 4All Randox Laboratories catalogs and technical brochures
-
VeraSTAT-V
16 Pages
-
VERASTAT
16 Pages
-
Endocrine Array
4 Pages
-
Cerebral Arrays
4 Pages
-
Thyroid Arrays
4 Pages
-
Respiratory Multiplex Array
8 Pages
-
LT107 Evidence Investigator
32 Pages
-
LT253 Molecular Diagnostics
20 Pages
-
Evidence Evolution
28 Pages
-
Evidence
16 Pages
-
2018 Product List
84 Pages
-
The role of EQA in QC
8 Pages
-
Basic QC Stastics
8 Pages
-
Commutability Guide
4 Pages
-
How to measure uncertainty
8 Pages
-
ISO 15189 Educational Guide
8 Pages
-
Troubleshooting QC Errors
8 Pages
-
RX Monaco
20 Pages
-
Rx Imola
20 Pages
-
RX Daytona Plus
20 Pages
-
RX misano
20 Pages
-
Qnostics
52 Pages
-
RX SERIES ANALYSER OVERVIEW
24 Pages
-
RX modena
20 Pages
-
ACUSERA
101 Pages
-
LT033 RIQAS Explained
56 Pages
-
sdLDL-C
4 Pages
-
Adiponectin LT519
28 Pages
-
Specific Proteins
40 Pages
-
Linearity sets
12 Pages
-
Antioxidants
16 Pages
-
Cardiology & Lipid Testing
28 Pages
-
Diabetes Portfolio
28 Pages
-
Reagents Brochure
72 Pages
-
Total Bile Acids
4 Pages
-
VIVALYTIC
30 Pages
-
RANDOX DISCOVERY
36 Pages
-
HbA1c
2 Pages
-
Preparing QC
1 Pages
-
Point of Care Testing
12 Pages
-
LT394 Using QC Multirules
1 Pages
-
Guide to running QC
1 Pages
-
Tumour Marker Arrays
4 Pages
-
Which QC is the Right QC
8 Pages
-
How often is right for QC
6 Pages
-
Cardiac Risk Multiplex Array
4 Pages
-
LT241 Metabolic Array MAY15
8 Pages
-
KRAS / BRAF / PIK3CA Array*
4 Pages
-
Custom Arrays for Biochip
12 Pages
-
LT169 Cardiac Array
4 Pages
-
Rx Daytona
16 Pages
Archived catalogs
-
RIQAS Explained
36 Pages
-
Acusera
132 Pages
-
Metabolic Syndrome Arrays
8 Pages
-
STI Multiplex Array
8 Pages
-
Molecular Testing
16 Pages
-
Evidence Investigator
20 Pages
-
Fertility Array
4 Pages
-
Evidence Investigator
16 Pages
-
Evidence
16 Pages